Search Results

1 - 3 of 3 items :

  • European Union x
  • Basic Medical Science x
  • Clinical Medicine x
Clear All
Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia

REFERENCES 1. Kaakoush N, Castaño-Rodríguez N, Mitchell HM, et al. Global epidemiology of Campylobacter infection. Clin Microbiol Rev 2015; 28(3): 687–720. 2. EFSA, (European Food Safety Authority), ECDC (European Centre for Disease Prevention and Control), 2013. The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2011. EFSA Journal 2013; 11(4): 3129, 250 pp. 3. CDC, (Centers for Disease Control and Prevention). Preliminary Food Net data on the incidence of infection with pathogens

Open access
in PRILOZI
A Review of the Role of Exercise and Factors Affecting its Uptake for People with Chronic Kidney Disease (Ckd) not Requiring Renal Replacement Therapy/ Преглед На Улогата На Вежбањето И Факторите Што Влијаат На Неговата Примена Кај Лица Со Хронична Бубрежна Болест (Хбб) За Кои Не Е Потребна Бубрежна Заменска Терапија

Nephrology. 2005; 16: 180-188. 3. Roderick P, Roth M, Mindell J. "Prevalence of Chronic Kidney Disease in England: Findings from the 2009 Health Survey for England". Journal of Epidemiology and Community Health. 2011ч 65 (Suppl II): A12 4. Zoccali C, Kramer A, & Jager K. J. "Chronic Kidney Disease and End-stage Renal Disease - a review produced to contribute to the report". The status of health in the European Union: towards a healthier Europe. Nephrology Dialysis Transplantation. 2010; 3: 213-224. 5. Heiwe S, & Jacobson S. H

Open access
in PRILOZI
Establishment of the hemovigilance system in an oncology-based hospital of Nepal: A new starting in the field of blood transfusion in limited resource settings

requirements or a portion of the safety of patient improvement initiatives, hospital transfusion services report all the different hemovigilance happenings to federal, state, and non-governmental organizations (NGOs) [ 14 , 15 ]. In 2004, The Norwegian hemovigilance system initiated a system of reporting which is directed to professional and voluntary systems. In 2007, haemovigilance turned out to be the duty of an expert, according to the European Union (EU) blood instruction, and recording of serious adverse reactions (SARS) and serious adverse events (SAEs) grew into

Open access